The effect of the third dose of the BNT162b2 vaccine on anti-SARS-CoV-2 spike antibody levels in healthcare workers with and without COVID-19 infection

AIM: A third (booster) dose of the anti-SARS-CoV-2 vaccine became necessary due to the observed decrease in anti-SARS-CoV-2S antibody levels over time, new mutations, and low global vaccination rates. In this study, anti-SARS-CoV-2S antibody levels were measured (ECLIA assay) in 50 healthcare worker...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolszczak-Biedrzycka, Blanka, Bieńkowska, Anna, Cieślikiewicz, Beata, Smolińska-Fijołek, Elwira, Biedrzycki, Grzegorz, Dorf, Justyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970245/
https://www.ncbi.nlm.nih.gov/pubmed/36820816
http://dx.doi.org/10.1080/07853890.2023.2182907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970245/
https://www.ncbi.nlm.nih.gov/pubmed/36820816
http://dx.doi.org/10.1080/07853890.2023.2182907

Ejemplares similares